Sarepta???s Exondys 51 Saga Continues as More Details About FDA???s Criticism Uncovered Post author:Sam Post published:August 21, 2017 Post category:BioPharma August 22, 2017By Mark Terry… Source: BioSpace You Might Also Like Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017 Sartorius Stedim Biotech Presents The First Fully Integrated Upstream Platform April 13, 2017 Teva Shakes Up C-Suite in Restructuring November 26, 2017
Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017
